Nymox Pharmaceutical Corporation (NYMXF)
OTCMKTS · Delayed Price · Currency is USD
0.0900
0.00 (0.00%)
Feb 21, 2025, 10:00 AM EST

Nymox Pharmaceutical Statistics

Total Valuation

NYMXF has a market cap or net worth of 8.51 million. The enterprise value is 11.07 million.

Market Cap 8.51M
Enterprise Value 11.07M

Important Dates

The next estimated earnings date is Friday, March 14, 2025.

Earnings Date Mar 14, 2025
Ex-Dividend Date n/a

Share Statistics

NYMXF has 94.54 million shares outstanding. The number of shares has increased by 2.87% in one year.

Current Share Class n/a
Shares Outstanding 94.54M
Shares Change (YoY) +2.87%
Shares Change (QoQ) +1.91%
Owned by Insiders (%) 44.12%
Owned by Institutions (%) 0.04%
Float 52.83M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -1.24
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.09

Current Ratio 0.09
Quick Ratio 0.01
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -49.67

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -806.75%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 132.54%
Revenue Per Employee n/a
Profits Per Employee -559,125
Employee Count 16
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -78.05% in the last 52 weeks. The beta is 8.74, so NYMXF's price volatility has been higher than the market average.

Beta (5Y) 8.74
52-Week Price Change -78.05%
50-Day Moving Average 0.10
200-Day Moving Average 0.12
Relative Strength Index (RSI) 47.67
Average Volume (20 Days) 12,041

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 0.24

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -8.35M
Pretax Income -8.95M
Net Income -8.95M
EBITDA -8.34M
EBIT -8.35M
Earnings Per Share (EPS) -0.10
Full Income Statement

Balance Sheet

The company has 41,000 in cash and 2.61 million in debt, giving a net cash position of -2.57 million or -0.03 per share.

Cash & Cash Equivalents 41,000
Total Debt 2.61M
Net Cash -2.57M
Net Cash Per Share -0.03
Equity (Book Value) -6.30M
Book Value Per Share -0.07
Working Capital -6.30M
Full Balance Sheet

Cash Flow

Operating Cash Flow -2.78M
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

NYMXF does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -2.87%
Shareholder Yield -2.87%
Earnings Yield -105.14%
FCF Yield n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a